Stay updated on Nivolumab in Pediatric Hypermutant Cancers Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in Pediatric Hypermutant Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in Pediatric Hypermutant Cancers Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The page revision label was updated to v3.3.4 and the previous v3.3.3 entry was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:20:26.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    Locations section updated with multiple sites across Massachusetts, Pennsylvania, New South Wales, Queensland, South Australia, British Columbia, and Ontario, and the revision label updated to v3.3.3. The HHS Vulnerability Disclosure link and several regional location entries were removed (Massachusetts, Pennsylvania, New South Wales, Queensland, South Australia, British Columbia, Ontario).
    Difference
    0.8%
    Check dated 2025-12-23T13:30:51.000Z thumbnail image
  5. Check
    60 days ago
    Change Detected
    Summary
    Publications section now states that publications are automatically filled from PubMed and adds Revision: v3.3.2; the previous PubMed note and Revision: v3.2.0 wording were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T17:41:07.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    Deleted the funding-status notice about potential information delays and the NIH Clinical Center's operating status.
    Difference
    0.4%
    Check dated 2025-11-17T17:28:32.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    The update appears to be cosmetic UI/formatting changes with no modification to core study details such as title, conditions, eligibility criteria, interventions, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T11:39:40.000Z thumbnail image
  8. Check
    110 days ago
    Change Detected
    Summary
    Key updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If there are no other changes, this is the main shift.
    Difference
    2%
    Check dated 2025-10-05T16:43:55.000Z thumbnail image

Stay in the know with updates to Nivolumab in Pediatric Hypermutant Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in Pediatric Hypermutant Cancers Clinical Trial page.